Ora H. Pescovitz

CIK: 0001519624

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MBX

MBX Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

MBX
MBX Biosciences, Inc.
Jun 4, 2026
Award(A)
Stock option (right to buy)
Direct
12.5K shares-
MBX
MBX Biosciences, Inc.
Jun 5, 2025
Award(A)
Stock option (right to buy)
Direct
16K shares-
MBX
MBX Biosciences, Inc.
Apr 8, 2025
Purchase(P)
Direct
7.7K shares at avg. $5.89$45K
MBX
MBX Biosciences, Inc.
Sep 12, 2024
Award(A)
Stock Option (Right to Buy)
Direct
16K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	MBX MBX Biosciences, Inc.	Award(A) Stock option (right to buy)	12,500	-	-	Direct
Jun 5, 2025	MBX MBX Biosciences, Inc.	Award(A) Stock option (right to buy)	16,000	-	-	Direct
Apr 8, 2025	MBX MBX Biosciences, Inc.	Purchase(P)	7,693	$5.89	$45,312	Direct
Sep 12, 2024	MBX MBX Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	15,963	-	-	Direct

1-4 of 4 transactions

About Pescovitz Ora H.

Pescovitz Ora H. (SEC CIK 0001519624) files insider reports with the SEC as Director of MBX Biosciences, Inc. (MBX).

Signal8 holds 5 ownership filings by Pescovitz Ora H. (1 Form 3, 4 Form 4), filed between Sep 12, 2024 and Jun 5, 2026. Those filings report 4 transactions, from Sep 12, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Pescovitz Ora H.'s filings is in CARMEL, IN.

Recent filings by Pescovitz Ora H.

Jun 4, 2026: Grant or award of MBX derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of MBX derivative securities (Form 4, code A).
Apr 8, 2025: Open-market purchase of MBX shares (Form 4, code P).
Sep 12, 2024: Grant or award of MBX derivative securities (Form 4, code A).

Other insiders filing for MBX Biosciences, Inc. (MBX)

Radovich Peter, Director
Azoulay Salomon, Chief Medical Officer
Smither John W, Chief Financial Officer
Hoerter Steven L., President and CEO
Mathers Edward T, Director
Heron Patrick J, Director

How to read Form 4 transaction codes